Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience

Article ID	Journal	Published Year	Pages	File Type
8951000	Cardiovascular Revascularization Medicine	2018	5 Pages	PDF

Abstract

A strategy of routine anticoagulation for 3-months after TAVR is well tolerated and associated with similar or lower bleeding risk compared to antiplatelet therapy.

Keywords

NOAC Transcatheter valve replacement VARC TAVR SAVR DAPT Safety BARC Transcatheter aortic valve replacement surgical aortic valve replacement computed tomography Bleeding Academic Research Consortium dual antiplatelet therapy novel oral anticoagulant Outcomes Anticoagulation Valve Academic Research Consortium

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Medicine

Preview

Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience

Authors

Sergey Gurevich, Brett Oestreich, Rosemary F. Kelly, Mackenzie Mbai, Stefan Bertog, Demetris Yannopoulos, Santiago Garcia,